Rosiglitazone: all 149 studies that test it
Page 2 of 2. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00333151Phase 3
- Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On InsulinCompletedNCT00329225Phase 4
- The Effect Of AVANDIA On The Late Asthmatic ResponseCompletedNCT00318630Phase 1
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00318422Phase 3
- The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic SyndromeCompletedNCT00314561Phase 4
- Treatment With Local PPARgamma Ligand in Distal Ulcerative ColitisStatus unknownNCT00309660Phase 1/2
- Metabolic and Renal Effects of Rosiglitazone in Kidney TransplantCompletedNCT00309309Phase 2
- Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.CompletedNCT00306696Phase 4
- Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 DiabetesCompletedNCT00306644Phase 4
- Rosiglitazone and Exercise in Patients With Type 2 Diabetes MellitusCompletedNCT00306176Phase 4
- Study of Niacin and Rosiglitazone in Dysmetabolic DyslipidemiaCompletedNCT00304993Phase 4
- BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-CompletedNCT00297063Phase 3
- Effect of RosiglitazoneCompletedNCT00285142Not applicable
- Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or RosiglitazoneTerminatedNCT00282945Not applicable
- Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideCompletedNCT00279045Phase 3
- Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty LiverTerminatedNCT00274495Phase 4
- Rosiglitazone Effects on Cognition for Adults in Later LifeStatus unknownNCT00242593Phase 2
- AVANDAMET Versus Metformin For Type 2 Diabetes MellitusCompletedNCT00241605Phase 4
- Prevention of Corticosteroid-induced Glucose IntoleranceStatus unknownNCT00240604Phase 3
- Rosiglitazone And Plaque Study for Type 2 Diabetes MellitusCompletedNCT00231387Phase 3
- Rosiglitazone Versus Placebo in Chronic Stable AnginaTerminatedNCT00225355Phase 4
- Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With AnginaWithdrawnNCT00225342Phase 4
- Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and RibavirinCompletedNCT00207402Phase 4
- Study In Patients With Insulin ResistanceCompletedNCT00197132Phase 3
- Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)CompletedNCT00193648Phase 1
- Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate CancerCompletedNCT00182052Phase 3
- Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney DiseaseWithdrawnNCT00169923Phase 2/3
- The Impact of Rosiglitazone on Regression of AtherosclerosisSuspendedNCT00166803Not applicable
- Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.CompletedNCT00154011Not applicable
- Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum MalariaCompletedNCT00149383Phase 1/2
- Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood VesselsCompletedNCT00143624Not applicable
- The Study of Atherosclerosis With Ramipril and RosiglitazoneCompletedNCT00140647Phase 3
- Rosiglitazone Plaque StudyStatus unknownNCT00123227Phase 3
- Effect of Rosiglitazone on Peritoneal Cytokines in Women With EndometriosisWithdrawnNCT00121953Phase 2/3
- Rosiglitazone Versus Theophylline in Asthmatic SmokersCompletedNCT00119496Phase 2/3
- Use of Rosiglitazone in the Treatment of EndometriosisTerminatedNCT00115661Phase 2
- Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)CompletedNCT00110851Phase 2
- Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid CancerStatus unknownNCT00098852Phase 2
- The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) TrialCompletedNCT00095654Phase 3
- Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderWithdrawnNCT00084578Not applicable
- Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.CompletedNCT00069836Phase 3
- A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II DiabeticsCompletedNCT00067951Phase 3
- Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II DiabetesCompletedNCT00064727Phase 2
- Efficacy and Safety In Poorly Controlled Type 2 DiabeticsCompletedNCT00044460Phase 4
- Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue MaldistributionCompletedNCT00025753Not applicable
- Insulin, Neurogenetics and Memory in Alzheimer's DiseaseCompletedNCT00018382Phase 2
- Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat AbnormalitiesCompletedNCT00015691Not applicable
- Rosiglitazone in the Treatment of HIV-Associated HyperlipidemiaCompletedNCT00006493Phase 2
- Rosiglitazone in Treating Patients With LiposarcomaCompletedNCT00004180Phase 2